Skip to content
Company search
Company

Pharmability AB

5591490213 · Stockholm

Normal register statusSNI 72101SNI 21200SNI 72109Övriga aktiebolag1 workplace in SCB register

Källa: Bolagsverket och SCB, egen bearbetning

Overview

Company at a glance

Pharmability AB has registration number 559149-0213. Net revenue was 21.63 MSEK for the period ending 31 Dec 2025. Operating result was -2.93 MSEK for the period ending 31 Dec 2025. Reported average number of employees: 1 (31 Dec 2025).

Legal form
Övriga aktiebolag
County
Stockholms län
Registered
13 Feb 2018
Status
Normal register status
Industry
Bioteknisk forskning och utveckling

Latest value for each metric. Each value shows its own period.

What changed

We need two digital reports to show what changed. The next comparison appears when the company files its next report.

Financial history

Net revenue · MSEK

Show as table
PeriodNet revenue
2024-120.0
2025-1221.6

Where the income went

Fiscal year ending 31 Dec 2025. From the income statement in the annual report.

Flows are built from the reported lines. Other is the gap between the total and the lines the report states. Click a flow for its source.

Financial history

Net revenue covers sales. Operating turnover is net revenue plus other operating income. Operating revenue, inventory changes and other items is a separate reported line.

Financials31 Dec 202531 Dec 2024
Net revenue
MSEK
Operating revenue, inventory changes and other items
MSEK
Operating result
MSEK
Result after financial items
MSEK
Result before tax
MSEK
Net result
MSEK
Personnel costs
MSEK
Employees
people
Total assets
MSEK
Equity
MSEK
Unrestricted equity
MSEK
Share capital
MSEK
Short-term debt
MSEK
Long-term debt
MSEK

Some values are missing. They show a dash, never zero. Cost lines retain their source sign. A positive cost amount is subtracted in the income statement; missing lines are not treated as zero.

Annual reports

PeriodFiledView evidence
1 Jan 2025 → 31 Dec 2025
K3
4 Jun 2026

Only digital annual reports are included. A missing year does not mean the authority has no filing.

For filings before 2025, the filing date represents the bulk-file week and may be approximate.

Register facts

Registered business description

Bolaget ska utveckla läkemedel mot infektioner och inflammatoriska sjukdomar samt med därmed förenlig verksamhet.

Postal address

Alviksvägen 1 16753 Bromma
Legal form
Övriga aktiebolag
Municipality / registered seat
Stockholm · 0180
County
Stockholm
Registered
13 Feb 2018
Business activity started
30 Mar 2018
SCB employee size class
1-4 anställda
F-tax
Registered
VAT
Registered
Employer
Registered

The SCB employee class is a range. The reported average employee count is shown separately with its fiscal period.

Register facts: SCB/Bolagsverket, updated 30 Oct 2026.

Källa: Bolagsverket och SCB, egen bearbetning

Available evidence

1 digital filings are available in Bolagsdelta. The latest period ends 31 Dec 2025.

Legal formÖvriga aktiebolag
SNI code72101, 21200, 72109

Källa: Bolagsverket och SCB, egen bearbetning

Bolagsdelta Pro

Follow what changes.

With Bolagsdelta Pro, keep the companies you follow together, compare full filings and review changes in your workspace.

Explore Pro

Auditor & signing

8 signatories in the latest filing

Personal names are shown to signed-in users with the appropriate plan.

Ordförande

Signatory

Signatory

Signatory

Signatory

Signatory

Signatory

Verkställande direktör

Calculated metrics

Calculated

Beräknade värden från rapporterade poster i årsredovisningarna, inte rapporterade nyckeltal. Varje punkt anger vilka poster och dokument som använts.

Colour compares each row with itself: darker is higher for that ratio. Click a cell for the calculation.

Financials31 Dec 202531 Dec 2024
EBIT margin
Margin after financial items
EBITDA
Revenue per employee
Personnel costs per employee
Debt to equity
Revenue growth—

Källa: Bolagsverket och SCB, egen bearbetning

Company in context

31 Dec 2025

Revenue growth2,163,058,400.0 %

7757 companies · 1-4 employees · nationwide

P25 -20.8 %P50 1.5 %P75 27.1 %
Above the third quartile
Operating margin-13.5 %

8942 companies · 1-4 employees · nationwide

P25 1.1 %P50 13.1 %P75 33.4 %
Below the first quartile
Equity ratio—

9484 companies · 1-4 employees · nationwide

P25 42.0 %P50 63.0 %P75 80.6 %
Revenue per employee21.6 MSEK

8193 companies · 1-4 employees · nationwide

P25 0.5 MSEKP50 0.9 MSEKP75 1.5 MSEK
Above the third quartile

Peers are companies with a digital annual report in the same industry (SNI, two digits), county and employee size class where at least 15 exist, otherwise a broader group.

Källa: Bolagsverket och SCB, egen bearbetning

Official industry statistics

Against the industry (SCB)

County + SNI 22024

SNI code 72 · Stockholm · TAB5693

The company's reporting period ends 31 Dec 2025. SCB's statistical year is shown above; the periods may differ.

CompanyMedian (P50)Middle 50% (P25–P75)
Operating margin-13.5 %
Equity ratio—

A comparable company value is unavailable in this data.

Return on total capital—

A comparable company value is unavailable in this data.

689 companies in the SCB group.

Källa: SCB, egen bearbetning

SCB

Workplaces

1 workplace in SCB register

1Workplace 59395533

Main workplace

ALVIKSVÄGEN 1, 16753 BROMMA

Stockholm · Stockholms län

1-4 anställda

72101 · Bioteknisk forskning och utveckling · 21200 · Tillverkning av läkemedel · 72109 · Annan naturvetenskaplig och teknisk forskning och utveckling

CFAR 59395533
StockholmUppsalaSödermanlandÖstergötlandJönköpingKronobergKalmarGotlandBlekingeSkåneHallandVästra GötalandVärmlandÖrebroVästmanlandDalarnaGävleborgVästernorrlandJämtlandVästerbottenNorrbotten1
Simplified county outlines from open data (okfse/sweden-geojson). Coordinates: SCB.

1 of 1 workplaces have a map position.

SCB · Tillväxtanalys

The company's industry in context

Bioteknisk forskning och utvecklingStockholms län

Each metric shows its statistical group and period. Company counts, leader ages and wages are national; regional series identify their county and industry group.

Companies in the industry4,831Sweden · SNI 72 · 2025
Operational leaders aged 55+—
Average monthly salarySEK 53,800 / month

Sweden · industry section M · SCB · 2025

Monthly salary is an industry average. Personnel cost is the company's total reported cost, not an average salary.

Size distribution and recruitment plans

Companies by employee size class · Sweden · 2025

0 employees
3,475
1–4 employees
842
5–9 employees
190
10–19 employees
142
20–49 employees
99
50–99 employees
50
100–199 employees
19
200–499 employees
9
500+ employees
5

Recruitment plans

Share of workplaces in Stockholms län, all industries.

Decrease over 10% · 2026K1
3.0 %
No change · 2026K1
45.0 %
Some decrease · 2026K1
7.0 %
Some increase · 2026K1
21.0 %
Unable to assess · 2026K1
19.0 %
Increase over 10% · 2026K1
5.0 %

Källa: SCB, egen bearbetning. Källa: Tillväxtanalys.

Common questions

What is the revenue of Pharmability AB?

Net revenue was 21.63 MSEK for the period ending 31 Dec 2025.

Where does the information come from?

Information is based on Bolagsverket and SCB, with our own processing. Each financial value links to its filing reference.

Why is some information missing?

Bolagsdelta covers digital annual reports and available register information. A dash means the information is missing from our coverage, never that its value is zero.

What personal information is shown here?

Public company pages show roles and counts. Names and original documents require sign-in and the appropriate access.